Otsuka Tolvaptan Open Label Rollover Study For Adpkd
Posted Date: May 15, 2019
- Investigator: Shashi Kant
- Type of Study: Drug
Tolvaptan is being studied as a possible treatment for autosomal dominant polycystic kidney disease (ADPKD). ADPKD is a disease that causes kidney cysts (cysts are like fluid-filled balloons), worsening kidney function, blood in the urine, kidney pain, high blood pressure, kidney stones, kidney infe
Criteria:
Inclusion: Previous Participation In Otsuka 156-13-210 Double Blind Study, Egfr >= 20 Exclusion: He
Keywords:
Kidney Disease, Adpkd, Cysts, Nephrology
For More Information:
Karen Case, Ccrp
513-559-3367
karen.case@uc.edu